Generics 26

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Epirubicin manufacturers

26 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

26 products found

epirubicin

Injection 10 mg/5 ml, 50 mg/25 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #30013
The company, established in 2016 and later restructured as a private limited entity in 2018, specializes in manufacturing APIs, advanced intermediates, and finished dosage forms. With robust relationships in the pharmaceutical industry, it has built a strong customer base of over 50 clients and achieved an annual turnover exceeding 200 crore. The company operates extensive facilities capable of scaling from lab-scale development to bulk production, supporting its global expansion strategy. Committed to ethical practices and social responsibility, the company aims to make healthcare affordable and accessible worldwide, with export markets across Asia, Latin America, and Africa.

Manufacturer usually replies in 42 days

epirubicin

Injection 10 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19639

This globally operating pharmaceutical company focuses on developing and manufacturing a broad range of affordable medications. They specialize in both prescription and over-the-counter drugs, including oncology treatments, antibacterials, injectables (both specialty and large volume), ophthalmic products, dermatological preparations, and veterinary pharmaceuticals. Their product portfolio also includes unique niche drugs and orphan products, showcasing their commitment to addressing diverse medical needs. The company boasts state-of-the-art manufacturing facilities located across several regions, adhering to strict quality standards recognized by international regulatory bodies like the WHO GMP, US FDA, and MCC. Their extensive global reach spans over 45 countries in Asia, Africa, Latin America, CIS, Europe, Australia, and the Pacific Ocean. The company's focus on research and development, coupled with its global manufacturing capabilities and commitment to quality, positions them as a key player in the international pharmaceutical market.

Manufacturer usually replies in 20 days

epirubicin

Injection 10 mg, 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21249

This CTD dossier owner and manufacturer company is a WHO-GMP certified manufacturer and exporter focused on producing a wide range of formulations including beta-lactam products, effervescents, injections, eye/ear/nasal drops, ointments, veterinary medications, hormones, and food supplements. They target key regions in the Middle East, Africa, and Asia with an emphasis on brand building in export markets. The company holds multiple awards for its product quality and export excellence. Their commitment to quality is reflected in their ISO 9001:2008 certification and they prioritize ethical decision-making and transparency. The broad range of products suggests a focus on both acute and chronic conditions.

Manufacturer usually replies in 27 days

Want to see all 26 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Epirubicin

Epirubicin used for chemotherapy is an anthracycline drug. It can be used to treat breast cancer, who already had surgery to remove the tumor. Epirubicin primarily treats breast and ovarian cancer, gastric cancer, lung cancer, and lymphomas. Like all anthracyclines, Epirubicin intercalates DNA strands resulting in complex formation. This complex inhibits DNA and RNA synthesis. Epirubicin kicks off DNA cleavage by topoisomerase II, which results in a mechanism leading to cell death. It is thought that it works by binding to the cell membranes and plasma proteins in the compound's cytotoxic effects. But it generates free radicals that cause DNA and cell damage. In some chemotherapies, it is favored over Doxorubicin, the most popular anthracycline because it has fewer side effects. Epirubicins different spatial orientation caused by hydroxyl group with opposite chirality accounts for its faster elimination and lower toxicity. Pfizer sells Epirubicin under the brand name Ellence, Pharmorubicin, or Epirubicin Ebewe in the USA and around the world. Upjohn applied for FDA approval for its node-positive breast cancer in 1984 but was turned down due to of lack of data. However, the first trials of Epirubicin in humans started and was published in the early 80s. In 1999 Pharmacia who by then merged with Upjohn, received FDA approval for the use as a component of adjuvant therapy in node-positive patients, however, this Patent protection expired in 2007.

Dosage and administration

Epirubicin is sold as a solution for injection. It is given through the intravenous injection route by placing the needle directly into the tube of a flowing IV solution, that goes into a vein or central line. Epirubicin is a vesicant and can cause extensive tissue damage and blistering if it escapes from the vein. Therefore it is critical that, it is administered by a nurse trained to gives this drug. Any signs of inflammation around the injected area call for immediate medical intervention.

The cost of Epirubicin

In the USA, the cost for an intravenous solution containing 2 mg is around $50 for a supply of 5 milliliters. Whereas in India, a supply of 10 Mg costs only USD 7.5.

How does Epirubicin Work?

Epirubicin, an antitumor antibiotic is made from natural products of species of the soil fungus Streptomyces. They are involved in actions during the multiple phases of the cell cycle and are considered cell-cycle specific. Chemotherapy that works well when cells are dividing is called cell-cycle specific therapies. The scheduling of injection is subject to the type of cells, the rate at which it divides, and the time when it is likely to have the most impact.

Finding Epirubicin Manufacturers and Suppliers:

The process of finding trusted Epirubicin manufacturers and Epirubicin suppliers can be made quicker and more accessible by using Pipelinepharma's online platform, a B2B a marketplace that lets you finalize the deals of pharmaceutical products in a matter of a few clicks. Also, it is easy to use the online platform to grow your business opportunities. The robust search engine makes it convenient to search for manufacturers and suppliers of Epirubicin. The search can be further refined with industry-specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. helping to get in contact with the preferred manufacturer and supplier readily.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.